Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP383 | DOI: 10.1530/endoabs.81.EP383

ECE2022 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (318 abstracts)

Does the insulin pump improve glycaemic control in patients with type 1 diabetes?

Messaoudi Najoua 1 , Imane Assarrar 1 , Nisrine Bouichrat 1 , Tahri Abir 1 , Siham Rouf 2 & Hanane Latrech 2


1Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Department of Endocrinology-Diabetology and Nutrition, Oujda, Morocco; 2Faculty of Medicine and Pharmacy of Oujda, Mohamed the First University, Department of Endocrinology-Diabetology-Nutrition, Laboratory of Epidemiology, Clinical Research and Public Health, Oujda, Morocco


Introduction: Insulin pump therapy is recommended more and more in type 1 diabetic patients in order to achieve and maintain optimal glycaemic control. The objective of our study was to determine the effectiveness of insulin pump therapy in improving metabolic control in type 1 diabetic patients.

Patients-Methods: This is a retrospective, descriptive and analytical study including 20 patients with type 1 diabetes treated by insulin pump, between 2017 and 2021. All patients received a clinical evaluation, analysis of the glycaemic cycle and a dosage of HbA1c at the time of the start of insulin pump and during the evolution. Statistical analysis was performed by SPSS version-21.

Results: The mean age of the patients was 16,8 ± 8,1 years with a sex ratio (M/F) of 0,42. Thirty per-cent were children. The mean duration of diabetes was 5,8 ± 4,8 years. Seventy-five per-cent of patients practiced functional insulin therapy. The indications for insulin pump treatment were mainly hypoglycaemia and instable diabetes. During follow-up, we found a statistically significant decrease in insulin requirements, improvement in mean HbA1c and maintenance of control during follow-up, with a marked reduction in the number of hypoglycaemia events per week.

Conclusion: Insulin pump therapy appears to be reliable and effective when used appropriately, combined with appropriate therapeutic education and glycaemic monitoring to maintain long-term glycaemic control.

Key words: Type 1 diabetes – insulin-pump – glycaemic-control

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.